Bulletin
Investor Alert

Market Pulse Archives

April 9, 2021, 8:44 a.m. EDT

NIH recommends Lilly and Regeneron's combination antibody treatments to people with mild and moderate COVID-19

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Regeneron Pharmaceuticals Inc. (REGN)
  • X
    Eli Lilly & Co. (LLY)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

The National Institutes of Health on Thursday recommended that patients with mild to moderate COVID-19 who are at high risk of worsening disease should be treated with monoclonal antibody cocktails. The recommendation was issued by the NIH's COVID-19 Treatment Guidelines Panel for Regeneron Pharmaceuticals Inc.'s /zigman2/quotes/203149337/composite REGN -0.11% casirivimab-imdevimab combination therapy and Eli Lilly & Co.'s /zigman2/quotes/200106384/composite LLY +0.65% bamlanivimab-etesevimab. (Prescribing bamlanivimab as a standalone treatment is no longer recommended because of its lack of efficacy against some of the new variants.) The panel said that in regions where variants are more common, it recommends using the Regeneron cocktail rather than the Lilly one, because it includes bamlanivimab. Lilly and Regeneron both received emergency authorizations for the first round of monoclonal antibody therapies in November; since then, both companies have released additional clinical-trial data and the authorizations for those products have been updated. Executives at both companies previously told MarketWatch that there has been slower-than-expected utilization of these therapies. Since the start of the year, Regeneron's stock is down 1.4%, shares of Lilly are up 8.1%, and the S&P 500 /zigman2/quotes/210599714/realtime SPX +1.49% has rallied 8.%.

/zigman2/quotes/203149337/composite
US : U.S.: Nasdaq
$ 516.62
-0.55 -0.11%
Volume: 785,747
May 14, 2021 4:00p
P/E Ratio
14.62
Dividend Yield
N/A
Market Cap
$55.04 billion
Rev. per Employee
$931,393
loading...
/zigman2/quotes/200106384/composite
US : U.S.: NYSE
$ 196.21
+1.27 +0.65%
Volume: 1.82M
May 14, 2021 4:03p
P/E Ratio
29.37
Dividend Yield
1.73%
Market Cap
$188.17 billion
Rev. per Employee
$701,137
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,173.85
+61.35 +1.49%
Volume: 1.91B
May 14, 2021 5:02p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.